247 related articles for article (PubMed ID: 8222811)
1. Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases.
Sanchez-Armengol A; Rodriguez-Panadero F
Chest; 1993 Nov; 104(5):1482-5. PubMed ID: 8222811
[TBL] [Abstract][Full Text] [Related]
2. Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies.
Rodriguez-Panadero F; Lopez-Mejias J
Chest; 1989 Feb; 95(2):320-4. PubMed ID: 2914482
[TBL] [Abstract][Full Text] [Related]
3. Thoracoscopic talc poudrage in malignant pleural effusions: effective pleurodesis despite low pleural pH.
Aelony Y; King RR; Boutin C
Chest; 1998 Apr; 113(4):1007-12. PubMed ID: 9554639
[TBL] [Abstract][Full Text] [Related]
4. Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT.
Bhatnagar R; Luengo-Fernandez R; Kahan BC; Rahman NM; Miller RF; Maskell NA
Health Technol Assess; 2020 Jun; 24(26):1-90. PubMed ID: 32525474
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
Kolschmann S; Ballin A; Gillissen A
Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
[TBL] [Abstract][Full Text] [Related]
6. [Thoracocentesis for the assessment of lung cancer with pleural effusion].
Martín Díaz E; Arnau Obrer A; Martorell Cebollada M; Cantó Armengod A
Arch Bronconeumol; 2002 Oct; 38(10):479-84. PubMed ID: 12372198
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of medical thoracoscopy and thoracoscopic talc poudrage in patients with exudative pleural effusion.
Verma A; Taha A; Venkateswaran S; Tee A
Singapore Med J; 2015 May; 56(5):268-73. PubMed ID: 26034319
[TBL] [Abstract][Full Text] [Related]
8. [Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].
Zhang W; Wang GF; Zhang H; Mu XD; Jin Z
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):600-2. PubMed ID: 19088831
[TBL] [Abstract][Full Text] [Related]
9. Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience.
Leemans J; Dooms C; Ninane V; Yserbyt J
Respirology; 2018 Jun; 23(6):613-617. PubMed ID: 29320805
[TBL] [Abstract][Full Text] [Related]
10. Pleurodesis, pH, and thoracoscopic talc poudrage.
Aelony Y
Chest; 1993 Nov; 104(5):1317-9. PubMed ID: 8222775
[No Abstract] [Full Text] [Related]
11. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of pleural fluid pH in malignant epithelial mesothelioma after talc poudrage.
Aelony Y; Yao JF; King RR
Respiration; 2006; 73(3):334-9. PubMed ID: 16679752
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions.
Diacon AH; Wyser C; Bolliger CT; Tamm M; Pless M; Perruchoud AP; Solèr M
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1445-9. PubMed ID: 11029359
[TBL] [Abstract][Full Text] [Related]
14. Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions.
Debeljak A; Kecelj P; Triller N; Letonja S; Kern I; Debevec L; Rozman A
J BUON; 2006; 11(4):463-7. PubMed ID: 17309178
[TBL] [Abstract][Full Text] [Related]
15. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
16. Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series.
Aelony Y; Yao JF
Respirology; 2005 Nov; 10(5):649-55. PubMed ID: 16268920
[TBL] [Abstract][Full Text] [Related]
17. Thoracoscopic talc poudrage pleurodesis for chronic recurrent pleural effusions.
Aelony Y; King R; Boutin C
Ann Intern Med; 1991 Nov; 115(10):778-82. PubMed ID: 1929026
[TBL] [Abstract][Full Text] [Related]
18. The effect of silver nitrate pleurodesis after a failed thoracoscopic talc poudrage.
Menna C; Andreetti C; Ibrahim M; Maurizi G; Poggi C; Barile R; Cassiano F; Rendina EA
Biomed Res Int; 2013; 2013():295890. PubMed ID: 24073398
[TBL] [Abstract][Full Text] [Related]
19. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.
Crnjac A; Sok M; Kamenik M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):432-6. PubMed ID: 15296910
[TBL] [Abstract][Full Text] [Related]
20. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease.
Burrows CM; Mathews WC; Colt HG
Chest; 2000 Jan; 117(1):73-8. PubMed ID: 10631202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
